The Freeman Hospital
Welcome,         Profile    Billing    Logout  
 6 Trials 
5 Trials

   Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Lewis, Joanne
ACTION, NCT05580562: ONC201 in H3 K27M-mutant Diffuse Glioma Following Radiotherapy (the Study)

Calendar Jan 2026 - Dec 2026: Final data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma
Calendar Jan 2025 - Mar 2025: Interim data from ACTION trial for newly diagnosed H3 K27M-mutant diffuse glioma
Recruiting
3
450
Europe, Canada, Japan, US, RoW
Dordaviprone (ONC201), Dordaviprone (ONC201) + Placebo, Placebo
Chimerix
H3 K27M, Glioma
08/26
08/26
CLINGLIO, NCT04250922 / 2018-000365-37: LAM561 With RT and TMZ for Adults With Glioblastoma

Active, not recruiting
2/3
140
Europe, RoW
LAM561, TMZ, RT
Laminar Pharmaceuticals, Laboratory Corporation of America, Northern Institute for Cancer Research, Newcastle, Theradis pharma, LIPODOM THERAPEUTICS
Primary Glioblastoma, Glioblastoma Multiforme
10/24
05/25
Zaman, Azfar
NCT06412250: A Multicenter Observational Registry to Evaluate Safety and Performance of Vivo ISAR (SECURE Global Registry)

Recruiting
N/A
2000
Europe, RoW
Translumina Therapeutics LLP, Iqvia Pty Ltd
Cardiovascular Diseases
05/26
05/26
ZODIAC, NCT05844566: OptimiZation Of Lipid Lowering Therapies Using a Decision Support System In Patients With Acute Coronary Syndrome.

Active, not recruiting
N/A
1584
Europe
Decision Support System (DSS)
Imperial College London, Sanofi, Axtria, Inc.
Acute Coronary Syndrome, Myocardial Infarction
11/24
11/24
OPTIMAL, NCT04111770: The Randomized Controlled Trial

Active, not recruiting
N/A
807
Europe
IVUS guided Percutaneous Coronary Intervention, QCA guided Percutaneous Coronary Intervention
ECRI bv, Philips Healthcare, Boston Scientific Corporation
Left Main Coronary Artery Stenosis
07/25
07/25

Download Options